Rethinking biosafety in research on potential pandemic pathogens
- PMID: 23047752
- PMCID: PMC3484391
- DOI: 10.1128/mBio.00360-12
Rethinking biosafety in research on potential pandemic pathogens
Abstract
If accidentally released, mammalian-transmissible influenza A/H5N1 viruses could pose a greater threat to public health than possibly any other infectious agent currently under study in laboratories, because of such viruses' likely combination of transmissibility and virulence to humans. We advocate explicit risk-benefit assessments before work on such pathogens is permitted or funded, improvement of biosafety practices and enforcement, and harmonization of criteria for permitting such experiments across government agencies, as well as internationally. Such potential pandemic pathogens, as they have been called, jeopardize not only laboratory workers and their contacts, but also the wider population, who should be involved in assessments of when such risks are acceptable in the service of scientific knowledge that may itself bear major public health benefits.
Similar articles
-
The H5N1 moratorium controversy and debate.mBio. 2012 Nov 1;3(5):e00379-12. doi: 10.1128/mBio.00379-12. mBio. 2012. PMID: 23047753 Free PMC article. No abstract available.
-
The pause on Avian H5N1 influenza virus transmission research should be ended.mBio. 2012 Nov 1;3(5):e00358-12. doi: 10.1128/mBio.00358-12. mBio. 2012. PMID: 23047750 Free PMC article.
-
Biocontainment in gain-of-function infectious disease research.mBio. 2012 Oct 9;3(5):e00290-12. doi: 10.1128/mBio.00290-12. mBio. 2012. PMID: 23047747 Free PMC article.
-
Mammalian-transmissible H5N1 influenza: facts and perspective.mBio. 2012 Feb 24;3(2):e00045-12. doi: 10.1128/mBio.00045-12. Print 2012. mBio. 2012. PMID: 22366820 Free PMC article. Review.
-
Molecular pathogenesis of H5N1 influenza virus infections.Antivir Ther. 2007;12(4 Pt B):617-26. Antivir Ther. 2007. PMID: 17944269 Review.
Cited by
-
Biosafety, biosecurity, and bioethics.Monash Bioeth Rev. 2024 Jun;42(1):137-167. doi: 10.1007/s40592-024-00204-3. Epub 2024 Jul 30. Monash Bioeth Rev. 2024. PMID: 39078602 Free PMC article. Review.
-
A machine learning toolkit for genetic engineering attribution to facilitate biosecurity.Nat Commun. 2020 Dec 8;11(1):6293. doi: 10.1038/s41467-020-19612-0. Nat Commun. 2020. PMID: 33293535 Free PMC article.
-
National-level biosafety norms needed for dual-use research.Front Public Health. 2014 Jul 14;2:84. doi: 10.3389/fpubh.2014.00084. eCollection 2014. Front Public Health. 2014. PMID: 25072050 Free PMC article. No abstract available.
-
Integrating evolutionary aspects into dual-use discussion: the cases of influenza virus and enterohemorrhagic Escherichia coli.Evol Med Public Health. 2021 Oct 26;9(1):383-392. doi: 10.1093/emph/eoab034. eCollection 2021. Evol Med Public Health. 2021. PMID: 34925844 Free PMC article. Review.
-
Containing the accidental laboratory escape of potential pandemic influenza viruses.BMC Med. 2013 Nov 28;11:252. doi: 10.1186/1741-7015-11-252. BMC Med. 2013. PMID: 24283203 Free PMC article.
References
-
- Van Kerkhove MD, et al. 2012. Comment on “Seroevidence for H5N1 influenza infections in humans: meta-analysis.” Science 336:1506 author reply, 1506 - PubMed
-
- Larson HJ, Cooper LZ, Eskola J, Katz SL, Ratzan S. 2011. Addressing the vaccine confidence gap. Lancet 378:526–535 - PubMed
-
- Murray CJ, Lopez AD, Chin B, Feehan D, Hill KH. 2006. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918–20 pandemic: a quantitative analysis. Lancet 368:2211–2218 - PubMed
-
- Klotz LC, Sylvester EJ. 2012. The unacceptable risks of a man-made pandemic. Bull. At. Sci. 2012 http://www.thebulletin.org/web-edition/features/the-unacceptable-risks-o...
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical